Miami, FL (PRWEB) March 12, 2012
A new study on the regulatory effects of lipids, more specifically Omega-3 and Omega-6, in promoting or preventing appetite, recommends sufficient consumption of EPA and DHA polyunsaturated fatty acids of Omega-3, in order to offset the appetite producing effects of excessive Omega-6, the other polyunsaturated fatty acids abundantly found in red meat. Nutri-Med Logic Corp adds that another recent study consisting of 6 daily dosage of Omega-3 for 4 weeks, followed by 10 weeks of weight maintenance, also resulted in weight loss in obese individuals.
The study by The NIH and University of Bergen investigated the role of excessive dietary intake of polyunsaturated fatty acids of Omega-6 and appetite (Endocannabinoid system), more specifically if excessive intake of Omega-6 would produce hyperactivity of this system and thus induce obesity.
Endocannabinoid system is modulated solely by Omega-6, which is implicated in many physiological processes such as appetite and mood.
In The NIH study, animals were divided to two groups. One group having high Omega-6 intake and the other group having low Omega-6 intake for 14 weeks. The study found that only the high Omega-6 intake group developed diet-induced obesity. However, when Omega-3 was added to the diet of this very same group, the metabolic pattern of the high Omega-6 intake group resembled the low Omega-6 intake group.
As the result, the study suggests the adipogenic (fat promoting) effect of Omega-6 can be prevented by consuming sufficient EPA and DHA and that Omega-3 intake normalizes the endocannabinoid tone (its hyperactivity).
Another very recent study, double-blind, randomized, controlled trial with two parallel groups, one having a diet consisting of fish oil (the richest source of Omega-3) also found that the fish oil group enjoyed an improved metabolic profiles and there was a significant reduction in fat mass for the fish oil group.
This study, which was done by School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callagha, Australia, and published in the January issue of British Journal of Nutrition, found that while highest weight loss in the fish oil group was seen at the week 14, but no additional weight loss was realized afterward. (Br J Nutr. 2012 Jan 3:1-9)
In conclusion, Nutri-Med Logic Corp agrees with both these studies, to wit Omega-3 is very beneficial in preventing some aspects of diet-induced obesity as well as body mass reduction in obese individuals but adds that Omega-3 diet is not a weight-loss system or weight-loss program. Nutri-Med Logic Corp adds that, based on the duration of these two important studies, any Omega-3 diet with intent to offset some of the aspects of diet-induced obesity or reducing body mass in obese individuals may have to follow the same time pattern as these two studies: 14 weeks.
Nutri-Med Logic Corp is also a producer of dietary supplements such as a Pharmaceutical Grade R-Alpha Lipoic Acid, a potent anti-oxidant and the dietary supplement of choice for the Diabetics, in Germany for decades;
Producer of PolyEnylPhosphatidylCholine (PPC 425mg), an extract of soy, a pure and effective dietary source of choline and the recommended dietary supplement for those with Fatty Liver and Alcoholic Liver Disease, in Europe for decades.
Nutri-Med Logic's products are Formulated Based on Nutritional Logic, made from the highest quality raw materials that are manufactured in pharmaceutical facilities, encapsulated in pharmaceutical facilities and packaged in pharmaceutical facilities.
It must be noted that the studies, sources or statements above have not been evaluated by The FDA and, thus, one should not relate the cause of any diseases, stated herein, to lack of the dietary supplements, stated herein, nor equate their supplementation to prevention, treatment or cure.